NCG 4.0: the network of cancer genes in the era of massive mutational screenings of cancer genomes
NCG 4.0 is the latest update of the Network of Cancer Genes, a web-based repository of
systems-level properties of cancer genes. In its current version, the database collects …
systems-level properties of cancer genes. In its current version, the database collects …
Comprehensive analysis of molecular biologic characteristics of pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm
M Tsujimae, A Masuda, T Ikegawa, T Tanaka… - Annals of Surgical …, 2022 - Springer
Background Pancreatic ductal adenocarcinoma (PDAC) concomitant with intraductal
papillary mucinous neoplasm (IPMN) is defined as PDAC occurring apart from IPMN. This …
papillary mucinous neoplasm (IPMN) is defined as PDAC occurring apart from IPMN. This …
Deep Sequencing of Cancer-Related Genes Revealed GNAS Mutations to Be Associated with Intraductal Papillary Mucinous Neoplasms and Its Main Pancreatic …
S Takano, M Fukasawa, S Maekawa, M Kadokura… - PloS one, 2014 - journals.plos.org
Background To clarify the genetic mutations associated with intraductal papillary mucinous
neoplasms (IPMN) and IPMN-related pancreatic tumours, we conducted cancer-related …
neoplasms (IPMN) and IPMN-related pancreatic tumours, we conducted cancer-related …
DNA methylation changes and somatic mutations as tumorigenic events in Lynch syndrome-associated adenomas retaining mismatch repair protein expression
S Mäki-Nevala, S Valo, A Ristimäki, V Sarhadi… - …, 2019 - thelancet.com
Background DNA mismatch repair (MMR) defects are a major factor in colorectal
tumorigenesis in Lynch syndrome (LS) and 15% of sporadic cases. Some adenomas from …
tumorigenesis in Lynch syndrome (LS) and 15% of sporadic cases. Some adenomas from …
Next-generation sequencing revealed TP53 mutations to be malignant marker for intraductal papillary mucinous neoplasms that could be detected using pancreatic …
S Takano, M Fukasawa, M Kadokura, H Shindo… - Pancreas, 2017 - journals.lww.com
Objectives The aims of this study were to identify the genetic mutations associated with
malignant intraductal papillary mucinous neoplasms (IPMNs) and evaluate the possibility of …
malignant intraductal papillary mucinous neoplasms (IPMNs) and evaluate the possibility of …
IQGAP3 in clear cell renal cell carcinoma contributes to drug resistance and genome stability
W Li, Z Wang, H Wang, J Zhang, X Wang, S Xing… - PeerJ, 2022 - peerj.com
Background Clear cell renal clear cell carcinoma (ccRCC) is resistant to most
chemotherapeutic drugs and the molecular mechanisms have not been fully revealed …
chemotherapeutic drugs and the molecular mechanisms have not been fully revealed …
Functional repair assay for the diagnosis of constitutional mismatch repair deficiency from non-neoplastic tissue
Purpose Constitutional mismatch repair deficiency (CMMRD) is a highly penetrant cancer
predisposition syndrome caused by biallelic mutations in mismatch repair (MMR) genes. As …
predisposition syndrome caused by biallelic mutations in mismatch repair (MMR) genes. As …
Targeting tumor tolerance: A new hope for pancreatic cancer therapy?
D Delitto, SM Wallet, SJ Hughes - Pharmacology & therapeutics, 2016 - Elsevier
With a 5-year survival rate of just 8%, pancreatic cancer (PC) is projected to be the second
leading cause of cancer deaths by 2030. Most PC patients are not eligible for surgery with …
leading cause of cancer deaths by 2030. Most PC patients are not eligible for surgery with …
GLI1 interferes with the DNA mismatch repair system in pancreatic cancer through BHLHE41-mediated suppression of MLH1
S Inaguma, M Riku, M Hashimoto, H Murakami, S Saga… - Cancer research, 2013 - AACR
The mismatch repair (MMR) system is indispensable for the fidelity of DNA replication, the
impairment of which predisposes to the development and progression of many types of …
impairment of which predisposes to the development and progression of many types of …
Alterations of epigenetic regulators in pancreatic cancer and their clinical implications
BR Silverman, J Shi - International journal of molecular sciences, 2016 - mdpi.com
Pancreatic cancer is one of the most aggressive human cancer types with a five-year
survival less than 7%. Emerging evidence revealed that many genetic alterations in …
survival less than 7%. Emerging evidence revealed that many genetic alterations in …